Cyclophosphamide Injection, Powder, Lyophilized, For Solution
Product Images NDC 39822-0260

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cyclophosphamide (NDC 39822-0260). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xgen Pharmaceuticals Djb, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ca1 Carton (Cy Ca1 00 Cder)

Cyclophosphamide for Injection, USP 1 g/vial lyophilized powder in a single-dose vial label. The label includes NDC 39822-0255-1 and highlights Cyclophosphamide as a cytotoxic agent for intravenous injection after reconstitution and dilution. It is manufactured for XGen Pharmaceuticals DJB, Inc., and contains storage and usage cautions.*

FDA Label Image

Ca2 Carton (Cy Ca2 00 Cder)

Packaging label for Cyclophosphamide for Injection, USP 2 g/vial, lyophilized powder for solution. The single-dose vial label warns it is a cytotoxic agent and specifies use after reconstitution for intravenous injection or infusion. Label includes storage information, manufacturer XGen Pharmaceuticals DJB, Inc., and NDC 39822-0260-1. The label also advises discarding unused solution and includes a warning to dilute further before intravenous infusion.*

FDA Label Image

Ca500 Carton (Cy Ca500 00 Cder)

Packaging label for Cyclophosphamide for Injection, USP, 500 mg per vial, lyophilized powder for solution. This single-dose vial is for intravenous use and contains 500 mg cyclophosphamide with 375 mg mannitol. It is labeled as a cytotoxic agent by XGen Pharmaceuticals DJB, Inc. The label includes usage instructions and a caution to discard unused solution.*

FDA Label Image

Vl1 Vial (Cy Vl1 00 Cder)

Label for Cyclophosphamide for Injection, USP lyophilized powder, 1 g per vial. The single-dose vial is a cytotoxic agent intended for intravenous use, manufactured by XGen Pharmaceuticals DJB, Inc. Instructions note each vial contains 1 g cyclophosphamide and 750 mg mannitol, with storage at or below 25°C (77°F).*

FDA Label Image

Vl2 Vial (Cy Vl2 00 Cder)

Label for Cyclophosphamide injection, USP, 2 g per vial as lyophilized powder for solution. It is a cytotoxic agent intended for intravenous use. The label includes dosage content, reconstitution cautions, storage instructions, and is manufactured by XGen Pharmaceuticals DJB, Inc.*

FDA Label Image

Vl500 Vial (Cy Vl500 00 Cder)

Label for Cyclophosphamide for Injection, USP 500 mg/vial lyophilized powder for intravenous use, labeled as a cytotoxic agent. The single-dose vial contains 500 mg cyclophosphamide and 375 mg mannitol. The label includes storage instructions, dilution cautions, and is manufactured for XGen Pharmaceuticals DJB, Inc. The NDC number 39822-0250-1 is displayed alongside a barcode.*

FDA Label Image

Cyclophosphamide Monohydrate Structure (Cyclophosphamide 01)

Chemical structure of Cyclophosphamide, depicting its characteristic ring and functional groups, including phosphate and nitrogen atoms, as well as a water molecule (H2O) indicating the hydrated form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.